Nacubactam Enhances Meropenem Activity Against Carbapenem-Resistant Klebsiella Pneumoniae Producing Klebsiella Pneumoniae Carbapenemases (KPC)

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00432-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

IMP-Producing Carbapenem-Resistant Klebsiella Pneumoniae in the United States

Journal of Clinical Microbiology
Microbiology
2011English

Molecular Epidemiological Insights Into Colistin-Resistant and Carbapenemases-Producing Clinical Klebsiella Pneumoniae Isolates

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Detection of KPC and Oxa-48 Gene in Clinical Isolates of Carbapenem Resistant Klebsiella Pneumoniae

2019English

Screening for Klebsiella Pneumoniae Producing Carbapenemase (KPC) in Prato (Italy)

Microbiologia Medica
2014English

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae

Journal of Clinical Medicine Research
2011English

Meropenem Heteroresistance in Clinical Isolates of OXA-48-producing Klebsiella Pneumoniae

Diagnostic Microbiology and Infectious Disease
MedicineInfectious DiseasesMicrobiology
2019English

Treatment and Outcomes in Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections

Diagnostic Microbiology and Infectious Disease
MedicineInfectious DiseasesMicrobiology
2011English

Carbapenem-Resistant Klebsiella Pneumoniae: Microbiology Key Points for Clinical Practice

International Journal of General Medicine
Medicine
2019English

The Threat of Carbapenem-Resistant Hypervirulent Klebsiella Pneumoniae (CR-HvKP)

Biomedical Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy